Grünenthal Group
Petra Danielsohn-Weil was born on 15 February 1960 in Herford, Germany. She studied Chemistry, Biology and Educational Psychology, and was awarded a PhD in Biology.
Petra Danielsohn-Weil has over 30 years of experience in the pharmaceutical industry. She spent a major part of her professional career in both strategic and operational roles at global, regional and local levels at Warner-Lambert and Pfizer.
Previously, she served in the Board of Directors of the “Association of Pharmaceutical Companies in Switzerland” (VIPS), the Advisory Board of the Frankfurter Allgemeine Zeitung Forum and the Board of Directors of the US-Russia Business Council. Currently, she serves as a Board Member and Independent Director at two corporations: NovaMedica and Invacare.
Petra Danielsohn-Weil is married and lives with her spouse in New York.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Grünenthal Group
5 followers
Grünenthal is a global leader in pain management and related diseases. As a science-based privately-owned pharmaceutical company, they have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide.